Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1)

glp1 · New England Journal of Medicine, 387(3), 205–216 · 2022

Jastreboff (2022) showed that by hitting two metabolic receptors instead of one, tirzepatide can melt away 20% of body weight—nearly matching the results of surgery.

Authors

Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al.

Research lens

Jastreboff (2022) showed that by hitting two metabolic receptors instead of one, tirzepatide can melt away 20% of body weight—nearly matching the results of surgery.

  • glp1
  • metabolism